Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters











Database
Language
Publication year range
1.
J Clin Psychopharmacol ; 35(2): 175-7, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25679134

ABSTRACT

Lithium treatment in rodents markedly enhances cholinergic agonists such as pilocarpine. This effect can be reversed in a stereospecific manner by administration of inositol, suggesting that the effect of lithium is caused by inositol monophosphatase inhibition and consequent inositol depletion. If so, inositol-deficient food would be expected to enhance lithium effects. Inositol-deficient food was prepared from inositol-free ingredients. Mice with a homozygote knockout of the inositol monophosphatase 1 gene unable to synthesize inositol endogenously and mimicking lithium-treated animals were fed this diet or a control diet. Lithium-treated wild-type animals were also treated with the inositol-deficient diet or control diet. Pilocarpine was administered after 1 week of treatment, and behavior including seizures was assessed using rating scale. Inositol-deficient food-treated animals, both lithium treated and with inositol monophosphatase 1 knockout, had significantly elevated cholinergic behavior rating and significantly increased or earlier seizures compared with the controls. The effect of inositol-deficient food supports the role of inositol depletion in the effects of lithium on pilocarpine-induced behavior. However, the relevance of this behavior to other more mood-related effects of lithium is not clear.


Subject(s)
Antimanic Agents/therapeutic use , Behavior/drug effects , Bipolar Disorder/drug therapy , Inositol/deficiency , Lithium Compounds/therapeutic use , Phosphoric Monoester Hydrolases/antagonists & inhibitors , Vitamin B Deficiency/psychology , Animals , Behavior, Animal/drug effects , Bipolar Disorder/psychology , Diet , Enzyme Inhibitors/pharmacology , Mice , Mice, Inbred ICR , Pilocarpine
2.
Psychopharmacology (Berl) ; 227(3): 503-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23344554

ABSTRACT

RATIONALE: Lithium has been a standard pharmacological treatment for bipolar disorder over the last 60 years; however, the molecular targets through which lithium exerts its therapeutic effects are still not defined. Attenuation of the phosphatidylinositol signal transduction pathway as a consequence of inhibition of inositol monophosphatase (IMPase) has been proposed as one of the possible mechanisms for lithium-induced mood stabilization. OBJECTIVES: The objective was to study the behavioral effect of the specific competitive IMPase inhibitor L-690,330 in mice in the lithium-sensitive pilocarpine-induced seizures paradigm and the forced swim test (FST). METHODS: The inhibitor was administered intracerebroventricularly in liposomes. RESULTS: L-690,330 increased the sensitivity to subconvulsive doses of pilocarpine and decreased immobility time in the FST. CONCLUSIONS: It is possible that the behavioral effects of lithium in the pilocarpine-induced seizures and in the FST are mediated through the inhibition of IMPase, but reversal of the inhibitor's effect with intracerebroventricular inositol would be an important further step in proof.


Subject(s)
Antipsychotic Agents/pharmacology , Behavior, Animal/drug effects , Diphosphonates/pharmacology , Lithium/pharmacology , Phosphoric Monoester Hydrolases/antagonists & inhibitors , Pilocarpine/pharmacology , Animals , Diphosphonates/administration & dosage , Diphosphonates/pharmacokinetics , Injections, Intraventricular , Liposomes , Male , Mice , Mice, Inbred ICR , Seizures/chemically induced , Seizures/enzymology , Seizures/psychology , Signal Transduction , Swimming
SELECTION OF CITATIONS
SEARCH DETAIL